Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether a short course of subcutaneous immunotherapy is efficacious in mite induced asthma. The efficacy is based on reduction in control medication.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
ALK-Abelló A/S
NCT05008965 · Allergic Asthma
NCT04699604 · Allergic Asthma
NCT01536522 · Asthma, Allergic Asthma, and more
NCT06151938 · Allergic Rhinitis Due to House Dust Mite, Allergic Asthma
NCT05186025 · Allergic Rhinitis Due to Pollen, Allergic Conjunctivitis, and more
Hospital Virgen del Camino, Allergology Service
Pamplona, Navarre
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions